life&brain Electrophysiology Services



Similar documents
Mechanisms of action of AEDs

Neurophysiology. 2.1 Equilibrium Potential

Corporate Presentation November, 2013

Pharmacology skills for drug discovery. Why is pharmacology important?

ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5

Alterações empresariais sustentadas pelo conceito de engenharia do Produto Patrício Soares da Silva, MD, PhD

Ageing Research in Trinity College

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version

Brain Computer Interfaces (BCI) Communication Training of brain activity

Chapter 8. Summary and Perspectives

Introduction to Psychology, 7th Edition, Rod Plotnik Module 3: Brain s Building Blocks. Module 3. Brain s Building Blocks

Neurobiology of Depression in Relation to ECT. PJ Cowen Department of Psychiatry, University of Oxford

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S7B

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON THE PRE-CLINICAL EVALUATION OF ANTICANCER MEDICINAL PRODUCTS

Introduction to Neurophysiological Psychology (PSY 451)

PART I: Neurons and the Nerve Impulse

Description of modules for the Master s course 2015/16 The English version is for general information only and not legally relevant.

Lecture One: Brain Basics

High throughput screening, high content screening, primary and stem cells. new techniques now converging

JUMISC JUMISC. For further information visit our website:

WebQuest: Neurotransmitters, Cravings & Addiction By: Sandra R. Holmes (page 1 of 18 )

Electrophysiological Recording Techniques

FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN

NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCEINCES Division of Extramural Research and Training

Luca Romagnoli, Ph.D. Business Development Manager

4.1 Objectives of Clinical Trial Assessment

Basic Overview of Preclinical Toxicology Animal Models

DIRECTORY OF GRANT AWARDS 2015 GRANT CYCLE

LIST OF FIGURES. Figure 1: Diagrammatic representation of electromagnetic wave. Figure 2: A representation of the electromagnetic spectrum.

BIOPHYSICS OF NERVE CELLS & NETWORKS

NIH Perspectives and Priorities Story C. Landis, PhD Director, NINDS January 10, 2011

Never Stand Stil Faculties of Science and Medicine

TGN 1412 Welche Änderungen haben sich für die Erstanwendung am Menschen aus Sicht des BfArM ergeben?

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES

Masters of Arts in Biology

Guidance for Industry Safety Testing of Drug Metabolites

exactly. The need for efficiency in developing effective new therapeutics has never been greater.

Non-clinical development of biologics

The Neuron and the Synapse. The Neuron. Parts of the Neuron. Functions of the neuron:

Resting membrane potential ~ -70mV - Membrane is polarized

Course Curriculum for Master Degree in Clinical Pharmacy

Neuro imaging: looking with lasers in the brain

Neuroscience and Brain Technologies. Research Themes

Supplemental Fig. S1. The schematic diagrams of the expression constructs used in this study.

I N V E S T O R P R E S E N TAT I O N B I O T R I N I T Y L o n d o n A p r i l

Bi 360: Midterm Review

Masters research projects. 1. Adapting Granger causality for use on EEG data.

CHAPTER- 6. Okadaic acid induced neurotoxicity leads to central cholinergic dysfunction in rats. 1. Introduction. 2. Methods

Master in Biology Faculty of Natural Sciences February 2010

Call 2014: High throughput screening of therapeutic molecules and rare diseases

Roche Position on Human Stem Cells

GENOMICS: REINVIGORATING THE FIELD OF PSYCHIATRIC RESEARCH

CELLS IN THE NERVOUS SYSTEM

SAFETY PHARMACOLOGY STUDIES FOR HUMAN PHARMACEUTICALS S7A

The Science Behind Exercise and Improved Motor Function in Parkinson s Disease

Biology Institute: 7 PhD programs Expertise in all areas of biological sciences

Rare Diseases: Common Issues in Drug Development Guidance for Industry

CHAPTER 5 SIGNALLING IN NEURONS

ASSISTANT PROFESSOR OF OPHTHALMOLOGY University of California, San Francisco effective July 1, 2014 Member of Neuroscience Graduate Program

Reflex Physiology. Dr. Ali Ebneshahidi Ebneshahidi

Standards Alignment Minnesota Science Standards Alignment Matrix

The Need for a PARP in vivo Pharmacodynamic Assay

Session 6 Clinical Trial Assessment Phase I Clinical Trial

Cognitive Neuroscience. Questions. Multiple Methods. Electrophysiology. Multiple Methods. Approaches to Thinking about the Mind

Name: Teacher: Olsen Hour:

Neuroscience An extra bit. Dr Sasha Gartside Institute of Neuroscience Newcastle University

ANIMATED NEUROSCIENCE

rmn² Teaching Program 2014

Computational Neuroscience. Models of Synaptic Transmission and Plasticity. Prof. Dr. Michele GIUGLIANO 2036FBDBMW

Masters Learning mode (Форма обучения)

LEUPHASYL A NEW PENTAPEPTIDE FOR EXPRESSION WRINKLES CODE: PD080. Date: June 2005 Revision: 1 A GMP PEPTIDE FOR COSMETIC APPLICATIONS

DMPK: Experimentation & Data

Bottlenecks in Clinical Source Material Acquisition. Aby J. Mathew, PhD May 5, 2009 ISCT Annual Meeting San Diego, CA

Chemical safety and big data: the industry s demands

Chapter 7: The Nervous System

A: Nursing Knowledge. Alberta Licensed Practical Nurses Competency Profile 1

Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Course Catalog Masters Degree: Neurosciences (Master of Science, M.Sc.)

Biophysics of Molecules

Learning with Your Brain. Teaching With the Brain in Mind


BSc in Medical Sciences with PHARMACOLOGY

Neurotrophic factors and Their receptors

Drugs, The Brain, and Behavior

12 Steps to Changing Neuropathways. Julie Denton

Top 20 National Universities. Undergraduate Curricula and Graduate Expectations

Slide 1: Introduction Introduce the purpose of your presentation. Indicate that you will explain how the brain basically works and how and where

Biologics: Specific Drug Safety Challenges. Violetta B. Kyburz

Treating Mental Disorders. Types of Biological Treatment. Drug Treatments for Psychological Disorders

Oncology Drug Development

WORKSHOPS CURRE T TRE DS I BIOMEDICI E

Laurie Regan, PhD, ND

MATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION

Extra-adrenal chromaffin cells of the Zuckerkandl s paraganglion: morphological and electrophysiological study.

A FDA Perspective on Nanomedicine Current Initiatives in the US

Case Study. Breakthroughs in Brain Research with High Performance Computing. High Performance Computing

NEURON AND NEURAL TRAMSMISSION: ANATOMY OF A NEURON. created by Dr. Joanne Hsu


WE THINK HE S SHARP TOO.

Transcription:

life&brain Electrophysiology Services

Life & Brain GmbH Electrophysiology Services NEUROPLASTICITY LIFE & BRAIN Gmbh Sigmund-Freud-Str. 25 53127 Bonn Tel.: 49-228-6885 215 Fax.: 49-228-6885 296 E-mail: Heinz.Beck@ukb.uni-bonn.de www.lifeandbrain.com

WHO WE ARE The NeuroPlasticity Platform provides contract research services to the Biotechnology and Pharmaceutical Industry and is an integral part of the Life and Brain GmbH. The development of new effective therapeutics for the majority of CNS diseases is challenged by the neuronal diversity and connectivity of the brain. This level of complexity requires understanding of organizational principles and cell-type specificity. Electrophysiology and functional connectomics are key tools in elucidating mechanisms of action underlying the pathophysiology of CNS disorders and facilitating the development of new therapeutics.

EVALUATE We support preclinical R&D programs in the areas of Neurodegeneration, Neurocognition and Functional Connectomics by providing electrophysiological characterization of small molecules with focus on target engagement, efficacy and potency in acute rodent and human brain slices, cultured neurons and animal models. DESIGN We provide longstanding expertise in understanding CNS drug actions at the level of ion channels, receptors and cellular excitability, and their effects on complex neuronal networks. In the field of Epilepsy, we focus on characterization of anticonvulsant therapies and pharmacoresistance, generally characterized by the failure of seizures to come under acceptable control in response to AED therapy. Overcoming resistance mechanisms is the most critical factor in the development of new anticonvulsant therapeutics with respect to clinical outcome as well as reduction of disease-related costs. As experts in pharmacoresistance we offer unique electrophysiological readouts for our clients to further drug development and competitive marketing activities. In the field of Functional Connectomics we investigate the structure-function relationship of neuronal circuits using engineered RABV and AAV viruses as tracers of synaptically connected neuronal populations in combination with optogenetic/electrophysiological and histological methods. EXECUTE Our team provides a flexible, highly skilled service with a proven track record of data quality and a keen sense for meeting corporate project timelines. Our collaborative culture ensures a well-designed study plan and execution.

SERVICES In vitro slice physiology Brain slices maintain functional local synaptic circuitry with preserved brain architecture, while allowing precise control of the extracellular environment and drug pharmacology. Replication of developmental aspects and regional specificity in brain slice preparations provides a suitable therapeutic screening system preceding in vivo efficacy studies. Whole cell patch clamp Measurement of neuronal excitability on a single cell-level is used to evaluate effects of pharmacological agents on distinct neuronal cell types, receptors, ion channels or neurotransmitter systems. Whole cell recordings are tailored to the specific characteristics and mechanism of action of the investigational substance. Synaptic transmission paired-pulse facilitation, inhibition spontaneous postsynaptic currents basal synaptic transmission agonist/antagonist evoked postsynaptic current input/output properties pre/postsynaptic activity evaluation of feed-back and feedforward inhibitory network motifs in CA1 neurons Intrinsic firing properties and ion channels voltage-dependent steady state activation and inactivation of ion channels (voltage-clamp recordings in isolated neurons) intrinsic firing properties (current clamp recording in slices) Neuronal cell type characterization pyramidal cell-interneurons-basket cells-olm cells-proximal dendritic cells Safety and Toxicity Evaluation of unwanted drug effects on basal neurotransmission and convulsive activity. dose-response curves off-target activity excipient testing Animal models of Epilepsy pilocarpine model of epilepsy in male wistar rats pilocarpine model of epilepsy in male CD-1 mice kainate model of epilepsy in male wistar rats Anticonvulsant drug pharmacology pharmacosensitivity of voltagedependent NA + channels comparative NA + channel-acting anticonvulsant activity anticonvulsant activity on neuronal inhibition/excitation Neuronal in-vitro preparations acutely dissociated dentate granule neurons acutely dissociated CA1 neurons in vitro assays voltage-clamp recordings from dissociated cells voltage-clamp recordings from transfected HEK293 and CHO cells in-vivo assays continuous telemetric EEG recordings in mice patch-clamp and extracellular recordings in mice Connectomics generation of RABV and raav virus constructs stereotactic virus delivery virus-mediated monosynaptic tracing from defined single neurons or neuronal populations whole brain tissue clearing image analysis and quantification of connected neurons microscopic visualization of connectomes

HEAD OF THE NEUROPLASTICITY UNIT Prof. Dr. Heinz Beck Dr. Beck studied Medicine in Cologne and was appointed a Professor of Experimental Epileptology and Cognition Research at the University of Bonn in 2004 and Head of the NeuroPlasticity unit within the Life & Brain GmbH in 2005. His interdisciplinary group has a strong track record investigating cellular and network mechanisms of excitability and synchronization in normal and diseased brain. A particular long-standing focus since more 20 years is the investigation of basic mechanisms of epilepsy in animal models and tissue obtained from epilepsy surgery. The group also has a particular track record in examining the mechanisms of CNS drug actions on the cellular and network level.

REFERENCES Function and developmental origin of a mesocortical inhibitory circuit.kabanova A, Pabst M, Lorkowski M, Braganza O, Boehlen A, Nikbakht N, Pothmann L, Vaswani AR, Musgrove R, Di Monte DA, Sauvage M, Beck H, Blaess S. Nat. Neurosci. 2015 Jun;18(6):872-82. Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug. Doeser A, Dickhof G, Reitze M, Uebachs M, Schaub C, Pires NM, Bonifácio MJ, Soaresda-Silva P, Beck H. Brain. 2015;138:371-87. Fluorescent-protein stabilization and high-resolution imaging of cleared, intact mouse brains. Schwarz MK, Scherbarth A, Sprengel R, Engelhardt J, Theer P, Giese G. PLoS One. 2015; 10:e0124650. Charting monosynaptic connectivity maps by two-color light-sheet fluorescence microscopy. Niedworok CJ, Schwarz I, Ledderose J, Giese G, Conzelmann KK, Schwarz MK. Cell Rep. 2012; 2(5):1375-86. Function of inhibitory micronetworks is spared by Na + channel acting anticonvulsant drugs. Pothmann L, Müller C, Averkin R, Bellistri E, Miklitz C, Uebachs M, Remy S, Menendez de la Prida L, Beck H. J. Neurosci. 2014, 34(29):9720-35. CUSTOMERS

LIFE & BRAIN GmbH NeuroPlasticity Sigmund-Freud-Str. 25 53127 Bonn Tel.: +49 (0)228 6885 215 Fax: +49 (0)228 6885 294 www.lifeandbrain.com